Fennec Announces Results of Annual Meeting

Rhea-AI Summary

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) announced the successful election of its director nominees at the Annual General Meeting held on June 14, 2022, in New York. All nominees received a strong majority of votes, with Dr. Khalid Islam receiving 99.59% in favor. Additionally, shareholders voted overwhelmingly (99.23%) to appoint Haskell & White LLP as auditors and approved the executive compensation package with 99.03% support. The meeting reflects strong shareholder confidence in the company's leadership and governance.

Positive

• 99.59% of votes in favor of the elected directors.
• Strong overall shareholder support for the business decisions made at the meeting.

Negative

• None.

RESEARCH TRIANGLE PARK, N.C., June 14, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 20, 2022 (the “Circular”) for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 14, 2022.

Detailed results of the vote for the election of directors are set out below:

Name of Nominee	Votes For	% Votes For	Votes Withheld	% Votes Withheld
Dr. Khalid Islam	15,884,541	99.59%	65,032	0.41%
Mr. Adrian Haigh	15,884,387	99.59%	65,186	0.41%
Mr. Chris A. Rallis	15,883,822	99.59%	65,751	0.41%
Mr. Marco Brughera	15,886,739	99.61%	62,837	0.39%
Dr. Jodi Cook	15,887,034	99.61%	62,539	0.39%
Mr. Rostislav Raykov	15,884,175	99.59%	65,398	0.41%

Shareholders voted 99.23% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, 99.03% in favour of the compensation paid to the Company’s named executive officers.

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144

FAQ

What were the results of the Fennec Pharmaceuticals AGM held on June 14, 2022?

The AGM saw the election of nominees with 99.59% support on average, and significant votes in favor for auditor appointment and executive compensation.

What percentage of shareholders voted for the appointment of Haskell & White LLP?

99.23% of shareholders voted in favor of appointing Haskell & White LLP as auditors.

Who were the elected directors at the Fennec Pharmaceuticals AGM?

Elected directors included Dr. Khalid Islam, Mr. Adrian Haigh, Mr. Chris A. Rallis, Mr. Marco Brughera, Dr. Jodi Cook, and Mr. Rostislav Raykov.

What was the vote percentage for executive compensation at Fennec Pharmaceuticals?

99.03% of shareholders supported the compensation paid to the company’s named executive officers.